Get startedLog in
    Picture of PhaseBio Pharmaceuticals logo

    PHASQ — PhaseBio Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: PhaseBio Pharmaceuticals Reports Qtrly Net Loss Per Common Share, Basic And Diluted $0.87

    Picture of PhaseBio Pharmaceuticals logoPhaseBio Pharmaceuticals
    13/05/2021 21:08
    May 13 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO REPORTS FIRST-QUARTER 2021 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
    * PHASEBIO PHARMACEUTICALS INC QTRLY NET LOSS PER COMMON
SHARE,
BASIC AND DILUTED $0.87

Source text for Eikon:  ID:nBw7Gkjzya 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PhaseBio Pharmaceuticals

    See all news